Nicholas Opalich, a distinguished executive from Northeast Ohio, has made an indelible mark in the pharmacy industry with his extensive experience spanning over twenty-five years. His expertise, particularly in the areas of mergers and acquisitions, has positioned him as a prominent figure in the field.
With a diverse background that includes leadership roles in hospice pharmaceutical claims processing, the pharmacy benefits sector, and drug manufacturing, he has honed a unique skill set. He has developed a deep understanding of various pharmacy operations, including hospice and palliative care. He has demonstrated proficiency in mail-order pharmacy systems, specialty infusion services, and medication delivery models. His leadership has played a crucial role in driving significant company valuations.
Opalich has also been instrumental in mentoring teams across a range of disciplines, including hospice pharmacy operations, medical benefits management, business development, and marketing. His holistic approach to leadership has benefitted numerous facets of the pharmacy industry.
An alumnus of David N. Myers University in Cleveland, Ohio, he holds bachelor's degrees in both pharmacy and business management. His education has laid a strong foundation for his impressive career trajectory.
Beyond his professional endeavors, Nick is a passionate philanthropist, supporting causes in animal welfare, poverty alleviation, public health, and homeless shelters. His interests include family, football, sailing, and wrestling, showcasing a well-rounded personality.
Currently, he is the Founder and CEO of HospiceChoice Rx, a company specializing in pharmacy benefit management for hospice care. Since its inception in 2023, HospiceChoice Rx has been committed to providing efficient pharmacy benefit administration with a strong focus on patient care and comfort. The company is actively engaging with major hospice providers to expand its services.
Previously, Nicholas founded OPSIA and OPSIC, contributing significantly to their growth and development. Under his leadership, OPSIA acquired OPSIC and evolved into Continental Healthcare, Inc., a leader in organ and bone marrow transplant services and a significant distributor for renowned drug companies.
In 2002, Nick Opalich founded Strategica Health Partners, a consultancy specializing in healthcare and pharmaceutical services. As CEO and managing partner, he guided the firm and its clients through various development stages, managing critical engagements with several high-profile clients. He concluded his tenure as CEO at Strategica in 2013 but continues as a managing partner.